By: Bennett Myers, MD, Director of DENT Multiple Sclerosis & Immunology Center and the DENT Spasticity Clinic. The following information is from the Mayo Clinic in Rochester, Minnesota. It is considered by many to be the top health care center in the world.
UB partners with CW Labs to advance cannabinoid science The original article can be found here. UB’s Center for Integrated Global Biomedical Sciences (CIGBS) will partner with Charlotte’s Web Labs (CW Labs) on a research initiative to advance understanding of the therapeutic uses of cannabinoids.
Navigating the Holidays and Alzheimer’s in the COVID-19 Era Information via the Alzheimer’s Association With COVID-19 surging across the country, families are struggling with decisions about the upcoming holiday season—weighing concerns about the safety of traveling and gathering with the desire to spend time with friends and relatives.
The Dent’s Family/Caregiver Policy during COVID is that we are limiting access to patients only unless absolutely necessary due to the size of our examination rooms and the need to remain as socially distant as possible for the health and safety of our patients and staff.
The MIND clinic is pleased to able to announce the establishment of a neuroscience lecture series that will be held every other Friday. This will be a webinar based lecture series by esteemed colleagues from United States, Hungary and Europe. The one hour lecture will be held on Friday’s at 8 AM (ET).
PRESS RELEASE Buffalo, NY July 12, 2020 DENT Neurologic Institute and BryLin Behavioral Health System, Inc. have coordinated a Memorandum of Understanding to strengthen the support to patients in our community especially as many individuals are suffering from severe depression during these most difficult times.
In light of current events, Dr. Horatio Capote opened discussion on how to deal with anxiety and stress, and how working together, as a community, can benefit all of us. Anxiety Anxiety is a “perfectly normal emotion…it’s how we’re built,
March 25, 2020 To our dear friends in the Western New York community, Please know that your DENT team is here for you, and remains open for all essential office, diagnostic and treatment services, including injections, infusion, imaging, and counseling.
On January 21, 2020, the U.S. Food and Drug Administration (FDA) approved Tepezza™ (teprotumumab-trbw) for the treatment of adults with Thyroid Eye Disease. This is a rare condition where the muscles and fatty tissues behind the eye become inflamed, causing the eyes to be pushed forward and bulge outwards (proptosis).
We understand that due to the amount of patients we have the privilege of taking care of that unfortunately that equates to high call volume for our patients to get through to us. In an effort to correct this issue, we have been diligently working on alternative options of communication for you!
